MSCL Stock Discussion
Satellos Bioscience Inc Description
Satellos Bioscience Inc., a regenerative medicine company, develops therapeutics that stimulate or restore muscle regeneration in severe disorders. Its lead program focuses on the development of a therapeutic for correcting the impaired muscle regenerative process in genetic pediatric disease, duchenne muscular dystrophy (DMD), a genetic disease that involves the mutation and functional disruption of the DMD gene and loss of Dystrophin. The company was incorporated in 2012 and is headquartered in Toronto, Canada.
Industry: Biotechnology
Keywords: Biology Organ Systems Regenerative Medicine
Recent Comments
- Deaddog on Deaddog Trades; Go ahead ask questions.
- Cos3 on Deaddog Trades; Go ahead ask questions.
- Deaddog on Deaddog Trades; Go ahead ask questions.
- SwingTradeBot on Market Recap for Tuesday, February 27, 2024
- SwingTradeBot on Market Recap for Monday, February 26, 2024
From the Blog
Featured Articles